Although we found that CPT and TSN treatment alone showed anti-cancer activity, CPT and TSN co-treatment can further significantly induce cancer cell death and suppress tumor growth, suggesting that TSN can be used as a positive synergist to help chemotherapy medication overcome drug resistance. The gene discussed is TSN; the disease is neoplasm.